Literature DB >> 1981160

Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions.

K F Shen1, S M Crain.   

Abstract

In a previous study, we demonstrated that cholera toxin-A subunit, as well as the whole toxin, selectively blocks opioid-induced prolongation of the Ca2+ component of the action potential duration (APD) in dorsal root ganglion (DRG) neurons, indicating mediation of this excitatory effect by Gs-linked opioid receptors. The present study shows that pretreatment of DRG neurons with the B subunit of cholera toxin (1-10 ng/ml; greater than 15 min) can also block mu/delta and kappa opioid-induced APD prolongation, but not shortening. Since the B subunit binds selectively to GM1 ganglioside located on the cell surface, these results suggest that this ganglioside may regulate Gs-linked excitatory opioid receptor functions in DRG neurons. Possible contamination of purified B subunit preparations of cholera toxin with traces of the more potent A subunit was eliminated by heating the stock solution to 56 degrees C for 20 min. Exposure of DRG neurons to an affinity-purified anti-GM1 antiserum also blocked opioid-induced APD prolongation, providing further evidence that GM1 ganglioside may play an essential role in excitatory opioid modulation of the action potential of these cells. The blockade by cholera toxin-B subunit and anti-GM1 antibodies of opioid-induced APD prolongation is best accounted for by the following hypothesis: CTX-B interferes with an endogenous GM1 ganglioside component of the excitatory, but not inhibitory, opioid receptor complex on DRG neurons that may allosterically regulate coupling of the receptors via Gs to adenylate cyclase/cyclic adenosine monophosphate-dependent ionic conductances.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981160     DOI: 10.1016/0006-8993(90)90751-v

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions.

Authors:  G Wu; Z H Lu; P Alfinito; R W Ledeen
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

Review 2.  Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence.

Authors:  S M Crain; K F Shen
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

3.  Genetic dissociation of morphine analgesia from hyperalgesia in mice.

Authors:  Gina F Marrone; Valerie Le Rouzic; Andras Varadi; Jin Xu; Anjali M Rajadhyaksha; Susruta Majumdar; Ying-Xian Pan; Gavril W Pasternak
Journal:  Psychopharmacology (Berl)       Date:  2017-03-25       Impact factor: 4.530

Review 4.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

Review 5.  Age as a factor in stress and alcohol interactions: A critical role for the kappa opioid system.

Authors:  Marvin Rafael Diaz; Kathryn Renee Przybysz; Siara K Rouzer
Journal:  Alcohol       Date:  2017-10-12       Impact factor: 2.405

Review 6.  Ganglioside function in calcium homeostasis and signaling.

Authors:  Robert W Ledeen; Gusheng Wu
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

7.  Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats.

Authors:  K R Przybysz; D F Werner; M R Diaz
Journal:  Neuropharmacology       Date:  2017-02-03       Impact factor: 5.250

8.  Contribution of G-Protein α-Subunits to Analgesia, Hyperalgesia, and Hyperalgesic Priming Induced by Subanalgesic and Analgesic Doses of Fentanyl and Morphine.

Authors:  Dionéia Araldi; Ivan J M Bonet; Paul G Green; Jon D Levine
Journal:  J Neurosci       Date:  2021-12-29       Impact factor: 6.709

9.  Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.

Authors:  S M Crain; K F Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  GM1 ganglioside modulates prostaglandin E1 stimulated adenylyl cyclase in neuro-2A cells.

Authors:  G Wu; Z H Lu; R W Ledeen
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.